BISCHOFBERGER NORBERT W 13D and 13G filings for Kronos Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-02 9:01 pm Sale | 2024-06-28 | 13D | Kronos Bio, Inc. KRON | BISCHOFBERGER NORBERT W | 12,681,108 21.100% | -1,470,834 (-10.39%) | Filing |
| 2024-06-12 7:32 pm Purchase | 2024-06-10 | 13D | Kronos Bio, Inc. KRON | BISCHOFBERGER NORBERT W | 14,151,942 23.600% | 3,527,205 (+33.20%) | Filing |
| 2023-11-27 4:41 pm Purchase | 2023-11-15 | 13D | Kronos Bio, Inc. KRON | BISCHOFBERGER NORBERT W | 10,624,737 17.400% | 4,689,577 (+79.01%) | Filing |
| 2022-02-17 4:14 pm Purchase | 2021-12-31 | 13G | Kronos Bio, Inc. KRON | BISCHOFBERGER NORBERT W | 5,935,160 10.500% | 14,356 (+0.24%) | Filing |
| 2021-05-04 4:01 pm Purchase | 2020-12-31 | 13G | Kronos Bio, Inc. KRON | BISCHOFBERGER NORBERT W | 5,920,804 10.600% | 5,920,804 (New Position) | Filing |